Related Experiment Videos
Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis
M S Pearle1, C G Roehrborn, C Y Pak
1Department of Urology, The University of Texas Southwestern Medical Center, Dallas 75235-9110, USA. margaret.pearle@email.swmed.edu
Objectives:
To determine the efficacy of commonly used medications in comparison with placebo or no treatment for the prevention of renal stone recurrence (metaphylaxis) as documented in the literature.
Methods:
A MEDLINE search identified 14 randomized, controlled trials comprising 20 treatment arms and 6 different drug therapies for the prevention of stone recurrence. The active treatment arms from each of the trials were combined, and the results were compared with those of the control or no treatment arms overall and for each category of drug therapy (thiazide diuretics, allopurinol, phosphate, magnesium, and alkali citrate). A meta-analysis was performed of the combined treatment and control arms for all trials from which sufficient data were provided, both for overall medical therapy and for thiazide treatment.
Results:
A statistically significant benefit of drug therapy for stone metaphylaxis was identified (P = 0.04), largely because of the benefit of thiazides compared with placebo or no treatment (P = 0.02). Allopurinol conferred no overall benefit, although the only trial evaluating therapy in hyperuricosuric patients showed a statistically significant benefit.
Conclusion:
Medical therapy for calcium stone disease reduces the incidence of recurrence. Although only thiazide diuretics among the drug therapies were shown to significantly reduce stone recurrence, variability in study design and study population precluded adequate analysis of other drug therapies such as alkali citrate. Standardization of study design and reporting should improve the evaluation of the efficacy of new drug treatments.
Insights
Medical therapy, particularly thiazide diuretics, effectively prevents kidney stone recurrence. Other medications showed no overall benefit, highlighting the need for standardized research in this area.
Area of Science:
- Nephrology
- Pharmacology
- Urology
Background:
- Kidney stone recurrence (metaphylaxis) is a significant clinical concern.
- Effective medical therapies are crucial for preventing recurrent stone formation.
Purpose of the Study:
- To evaluate the efficacy of common medications versus placebo for preventing kidney stone recurrence.
- To synthesize evidence from randomized controlled trials on medical metaphylaxis for renal stones.
Main Methods:
- A systematic literature search identified 14 randomized controlled trials.
- Meta-analysis combined data from 20 treatment arms across 6 drug classes.
- Efficacy was compared between active drug therapies and placebo or no treatment.
Main Results:
- Drug therapy demonstrated a statistically significant benefit in preventing stone recurrence (P=0.04).
- Thiazide diuretics showed a significant benefit compared to placebo (P=0.02).
- Allopurinol provided no overall benefit, though it was effective in hyperuricosuric patients.
Conclusions:
- Medical therapy, especially thiazide diuretics, reduces calcium stone disease recurrence.
- Further research with standardized designs is needed to assess other therapies like alkali citrate.
- Improved study standardization will enhance the evaluation of new drug treatments for stone metaphylaxis.